Morgan Stanley raised the firm’s price target on Colgate-Palmolive (CL) to $100 from $95 and keeps an Overweight rating on the shares. The firm sees Colgate-Palmolive as back on a path of 3%-4% organic sale growth going forward and is “becoming increasingly bullish” both longer and shorter-term, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target raised to $96 from $95 at JPMorgan
- Colgate-Palmolive Balances Growth Momentum With Margin Strain
- Colgate-Palmolive price target raised to $100 from $98 at Goldman Sachs
- Colgate-Palmolive Expands Strategic Growth and Restructuring Program
- Midday Fly By: Apple reports Q2 beat, oil majors post mixed results